OCT company wins 2008 Frost & Sullivan North America Award for Excellence in Research

March 10, 2008, Research Triangle Park, NC--Bioptigen has been awarded the Frost & Sullivan 2008 North American Excellence in Research Award for its work in spectral-domain optical coherence tomography (SD-OCT) for ophthalmology.

'Bioptigen is honored to receive this recognition from Frost & Sullivan for our developments in spectral domain optical coherence tomography (SDOCT). We are particularly proud of the dedication and passion of the talented team responsible for our progress,' commented Eric Buckland, co-founder and Chief Executive Officer of Bioptigen, Inc.

"Bioptigen and our collaborators in academia and industry recognize the importance of our SD-OCT implementation to pre-clinical research and development as well as to the clinical diagnosis of disease at its very earliest stages," said Eric Buckland, co-founder and CEO of Bioptigen.

Dr. Joseph Izatt, Bioptigen' s co-founder and CTO and Professor of Biomedical Engineering and Ophthalmology at Duke University, added, "This recognition is validation of our vision for the current and future potential of SD-OCT. Our emphasis looking forward is to extend the capabilities of our systems for functional imaging, and to search for new biomarkers of disease processes that will be uniquely accessible through the power of SD-OCT."

According to Frost & Sullivan analyst Rasika Ramachandran, Bioptigen's OCT imaging system is distinguished by demonstrably superior image quality, real time acquisition, processing and display, and a very high degree of flexibility.

"The company provides research-grade equipment into markets as diverse as ophthalmology, oncology, orthopedics, and genomics, with flexibility in delivery optics and software," Ramachandran said. "At the same time, their platform can be rapidly configured for ease of use in clinical diagnostics. With the unique performance and flexibility of their system, Bioptigen and its technology are poised for success."

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

NIR spectroscopy intravascular imaging system receives $25M investment

Medical device maker Infraredx has received a $25 million equity investment from Nipro Corporation, which builds on an exclusive agreement between the two companies for distribution of Infraredx's ...

OCT pioneer Fujimoto selected as 2014 IEEE Photonics Award winner

James Fujimoto, the Elihu Thomson Professor of Electrical Engineering at the Massachusetts Institute of Technology (MIT), has been selected for the 2014 IEEE Photonics Award.

OCT combo system receives FDA clearance, begins shipping worldwide

Ophthalmic device maker Optovue has received FDA 510(k) clearance for its iFusion combination system, which pairs the company's iVue spectral-domain optical coherence tomography (SD-OCT) system and...

OCT symposium emphasizes key applications

Overviews of biomedical imaging in general, and optical coherence tomography (OCT) in particular, kicked off the first international symposium hosted last week by the Center for Biomedical OCT Rese...


Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...



Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS